News release

Date: 12th December 2007

Toumaz Technology Secures International Patents for Core Sensium? Technology

Toumaz Gains Patent Protection in Australia For AMx? Ultra Low Power System-on-Chip (SOC) Signal Processing Technology; Adds to Patent Grants in UK and US

Abingdon, United Kingdom, December 12, 2007 – Toumaz Technology Limited, the leading provider of ultra-low power wireless infrastructure for body monitoring solutions, announces today that it has secured a patent in Australia for its AMx™ (Advanced Mixed Signal) technology – the technology behind Toumaz’s Sensium™ platform.

To support its accelerating commercialisation and growth, Toumaz is gaining international patent protection for the core Sensium technology in the major global markets. The Sensium is enabling a new generation of low-cost, non-intrusive wireless vital signs monitors for healthcare and lifestyle markets.

The granting of this latest patent adds to the existing protection achieved in the UK and the US. Earlier this year, Toumaz announced an agreement with Healthe International – a leading health and wellness group operating in Australia and the Asia Pacific market – to develop Sensium-based applications for elite athlete training and optimisation of sports performance.

The Australian patent covers the core technology that enables the Sensium platform to operate using orders of magnitude lower power than previously required, enabling a dramatic reduction in battery size for portable devices. As well as enabling real time data measurement and processing, AMx offers designers greater efficiency, reduced complexity and reduced silicon area for many applications. The dramatic reduction in peak current allows new types of ultra small form factor/thin flexible batteries to be used – yielding months or years of operational life from a single battery.

“The protection of our proprietary core technology in the key markets across the world is fundamental as we move into this key phase of market development for Sensium-enabled products,” comments Keith Errey, COO and Chief Operating Officer for Toumaz.

Toumaz’s groundbreaking Sensium sensor interface and transceiver platform enables intelligent, real-time, ultra-low power wireless monitoring of multiple vital signs – such as ECG, heart rate, body temperature, respiration and physical activity – via standard handheld devices such as mobile phones.

The unique combination of ultra-low power wireless and signal processing in one small System-on-Chip, allows the economies of scale of the semiconductor industry to be harnessed to provide highly functional, robust, low cost, disposable and non-intrusive monitors for a wide range of healthcare and lifestyle management applications.

– ends –

About Toumaz Technology (
Toumaz Technology Limited is the leading provider of ultra-low power wireless infrastructure for body monitoring solutions.

Toumaz’s ultra low-power smart sensor interface and transceiver platform – the Sensium™ –
enables non-intrusive, real-time wireless monitoring of multiple vital signs for a wide range of healthcare and lifestyle management applications. Based on Toumaz’s patented ultra-low power Advanced Mixed Signal (AMx)™ technology, the Sensium provides the enabling technology to connect the mobile individual to healthcare providers – simply, affordably and unobtrusively.

For healthcare professionals, this transforms the possibilities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible, personalised healthcare, as well as better therapeutic outcomes.

Press contacts:

Nicky Davis
EvokedSet PR
toumaz [at] evokedset [dot] com
Phone: +44 870 285 1650

Close This Window